Dr Reddys Laboratories Share Price Today - Live Blog for August 22, 2025

Increased investor interest has propelled Dr Reddys Laboratories Ltd's stock to a significant 0.10% gain, with the share price now at ₹1,276.30. Notably, the stock's PE ratio stands at 18.3000, and its Return on Equity (ROE) is 16.8559%.

The stock of Dr Reddys Laboratories Ltd is on the rise, registering an impressive 0.10% increase and currently trading at ₹1,276.30 per share. Investors are taking notice of this upward momentum.

Dr Reddys Laboratories Ltd shares saw a -0.37% decrease, reaching a current market price of ₹1,275.05. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 18.3000, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd's share price has fallen by -0.01%, a situation worth noting. At present, the stock is trading at ₹1,279.50. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 18.3000, while the industry PE ratio is 34.8831.

Dr Reddys Laboratories Ltd share price surged by 0.06%. With its current market price standing at ₹1,281.50 per share, this stock is garnering increased attention from the investment community.

Dr Reddys Laboratories Ltd witnessed a substantial 0.06% increase in its share price and is currently trading at ₹1,281.50. This remarkable performance has caught the eye of investors.

Dr Reddys Laboratories Ltd shares experienced a -0.08% reduction, with the current market price at ₹1,280.70. Investors are carefully considering their positions and seeking insights into the stock's future performance.

Dr Reddys Laboratories Ltd's share price has fallen by -0.00%, a situation worth noting. At present, the stock is trading at ₹1,281.70. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 18.3000, while the industry PE ratio is 34.8831.

Dr Reddys Laboratories Ltd's stock has surged by 0.32%, and it is currently trading at ₹1,282.65. Additionally, the stock maintains a PE ratio of 18.3000, while the industry PE is 34.8831.

The share price of Dr Reddys Laboratories Ltd recently experienced a positive upturn, resulting in a 0.32% increase. Presently, it is actively trading at ₹1,282.65.

The share price of Dr Reddys Laboratories Ltd has plummeted by -0.05%, signalling a challenging period. Currently trading at ₹1,279.25, this stock has caught the eye of bargain hunters, who may be considering their entry points.

Dr Reddys Laboratories Ltd's share price rallied by 0.07%, reaching the current market price of ₹1,280.00. This surge is indicative of the stock's recent positive performance.

Dr Reddys Laboratories Ltd shares saw a decrease of -0.02%, reaching a current market price of ₹1,278.50. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.

The share price of Dr Reddys Laboratories Ltd plunged by -0.02%, leaving investors concerned. At this moment, the stock can be acquired at ₹1,278.50, but investors are assessing whether this is a temporary dip or a long-term trend.

Dr Reddys Laboratories Ltd observed a -0.11% decrease in its share price, a situation that merits attention. As of now, it's actively trading at ₹1,278.75. The stock has a PE ratio of 18.3000, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

The stock of Dr Reddys Laboratories Ltd is facing a -0.12% decline and is currently trading at ₹1,280.30 per share. Investors are closely monitoring this situation for potential signs of a turnaround.

The share price of Dr Reddys Laboratories Ltd experienced a -0.30% slump and is currently trading at ₹1,279.40. While the stock maintains a PE ratio of 18.3000, the industry PE is 34.8831, raising questions about valuation.

Dr Reddys Laboratories Ltd has had quite the run lately, experiencing a substantial 0.25% uptick in its share price. As a result, it's now actively trading at ₹1,283.15 per share, making it an attractive option for investors.

Dr Reddys Laboratories Ltd displayed no price movement, holding steady at ₹1,277.05. Interestingly, the stock maintains a Price-to-Earnings (PE) ratio of 18.3000, while the industry PE ratio stands at 34.8831, which might influence investors' decisions.

There was no change in the share price of Dr Reddys Laboratories Ltd, and it continues to trade at ₹1,277.05. The stock has a PE ratio of 18.3000, an ROE of 16.8559%, and a debt to equity ratio of 0.1394.

In the financial arena, Dr Reddys Laboratories Ltd's stock price has increased by 0.08%, with its current market value per share resting at ₹1,278.05. This development highlights the stock's appeal to investors.

Dr Reddys Laboratories Ltd's share price has experienced a notable 0.08% upswing, and it's currently trading at ₹1,278.05 per share. Investors are closely watching this development.

Dr Reddys Laboratories Ltd experienced a substantial 0.91% boost in its share price and has garnered significant attention from the market. It's now trading at ₹1,277.05, making it an appealing option for investors.

Dr Reddys Laboratories Ltd share price surged by 0.91%. With its current market price standing at ₹1,277.05 per share, this stock is garnering increased attention from the investment community.

With a -0.37% decrease, Dr Reddys Laboratories Ltd's share price is now ₹1,266.55. Investors should examine the factors driving this decline. The stock's PE ratio is 18.3000, whereas the industry PE ratio stands at 34.8831.

Dr Reddys Laboratories Ltd's share price has fallen by -0.33%, a situation worth noting. At present, the stock is trading at ₹1,272.40. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 18.3000, while the industry PE ratio is 34.8831.